chuminhua2020-08-17 15:56
8月17日,赛诺菲(Sanofi)$赛诺菲-安万特(SNY)$ 和Principia Biopharma$Principia Biopharma(PRNB)$ (一家专注于开发免疫介导疾病治疗方法的后期生物医药公司)达成最终收购协议,交易总额约36.8亿美元。赛诺菲和Principia董事会一致批准了这笔交易。通过此次收购,赛诺菲获得Principia在研的3款...查看全文
chuminhua2020-07-18 16:28
7/16,一名熟悉内情的匿名人士告诉彭博社,Sanofi$赛诺菲-安万特(SNY)$ 正准备斥资500亿美元用于收购交易,重点是生物技术公司和治疗多发性硬化症及免疫疾病的资产。据传闻,主要目标是CNS和免疫学生物技术公司Principia Biopharma$Principia Biopharma(PRNB)$ ,两家公司已经建立了合作伙伴关系。...查看全文
资本主义拉美行不通2020-07-18 13:50
$Principia Biopharma(PRNB)$ 来神棍一把,Principia Biopharma, a Sanofi Company, 周一买入查看全文
牛唐2019-11-12 22:02
$Ovid Therapeutics(OVID)$又一个 没发数据就增发,学$Principia Biopharma(PRNB)$ 的吗,害怕数据不好
$Karyopharm(KPTI)$查看全文
chuminhua2019-10-12 10:39
10/11,在与AbbVie分手数月后,Principia $Principia Biopharma(PRNB)$ 宣布BTK抑制剂PRN1008用于寻常型天疱疮de II期开放标签试验B部分的数据。15名入组患者中,6名完全康复,4名仍在治疗,9名患者达到PDAI评分0或1。A部分研究时间是12周,B部分为24周,完全康复的比例从25%增至40%。PRN1008于201...查看全文
淘沙见金2018-09-15 01:48
$Principia Biopharma(PRNB)$ 做口服BTK抑制剂的小分子公司。IPO定价17,八月份刚刚发行的C轮价格 $14.38,IPO第一天股价轻松翻倍。今年做生物医药VC真是不错查看全文
$Principia Biopharma(PRNB)$ 5 Annual statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-009736 Size: 6 KB 网页链接
$Principia Biopharma(PRNB)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001387131-20-001835 Act: 34 Size: 73 KB 网页链接
$Principia Biopharma(PRNB)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-20-021826 Act: 34 Size: 74 KB 网页链接
$Principia Biopharma(PRNB)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-20-021754 Act: 34 Size: 96 KB 网页链接
$Principia Biopharma(PRNB)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000929638-20-000322 Act: 34 Size: 123 KB 网页链接
$Principia Biopharma(PRNB)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000921895-20-000547 Act: 34 Size: 289 KB 网页链接
$Principia Biopharma(PRNB)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-20-019983 Act: 34 Size: 83 KB 网页链接
$Principia Biopharma(PRNB)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-20-033448 Act: 34 Size: 161 KB 网页链接
$Principia Biopharma(PRNB)$ 内部交易: 2020-02-10,Chief Scientific Officer,Goldstein David ,卖出,6000普通股, $70.90
$Principia Biopharma(PRNB)$ 内部交易: 2020-02-10,Chief Scientific Officer,Goldstein David ,期权,6000普通股, $3.00